TABLE 13.
Annual Rates of Efficacy Parameters in Pediatric Patients With PIDD Treated With Privigen® for 12 Months
| End Point | Children (3–11 Years) [n=19] | Adolescents (12–15 Years) [n=12] | Total [n=31] |
|---|---|---|---|
| Total number of study days | 6,152 | 3,776 | 9,928 |
| Annual rate of aSBIs per patient | 0.12 | 0.10 | 0.11 |
| No. of patients with aSBI | 2 | 1 | 3 |
| No. of aSBIs | 2 | 1 | 3 |
| Annual rate of all infections per patient | 4.63 | 2.42 | 3.79 |
| No. of patients with infections | 17 | 11 | 28 |
| No. of infections | 78 | 25 | 103 |
| Annual rate of days missed from school/daycare per patient | 11.51 | 4.83 | 8.97 |
| No. of patients who missed | 16 | 7 | 23 |
| No. of days missed | 194 | 50 | 244 |
| Annual rate of days hospitalized per patient | 0.53 | 0 | 0.33 |
| No. of patients hospitalized | 5 | 0 | 5 |
| No. of days hospitalized | 9 | 0 | 9 |
| Annual rate of days with antibiotics per patient | 47.88 | 56.64 | 51.21 |
| No. of patients treated with antibiotics | 16 | 9 | 25 |
| No. of days on antibiotics | 807 | 586 | 1,393 |
Source: Adapted from Church 2009.